Literature DB >> 11067906

Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor.

C Pioli1, L Gatta, V Ubaldi, G Doria.   

Abstract

Although a large amount of information is available on the activity of CTLA-4 in T cells, the role of this receptor in B cells has not been previously characterized. Our results show that CD40 or LPS stimulation in the presence of IL-4 induces CTLA-4 expression in purified B cells; the maximum level is reached in both membrane and intracellular compartments after 48-72 h. Engagement of the B cell CTLA-4 by immobilized mAb inhibits IgG1 and IgE production and reduces the frequency of IgG1- and IgE-expressing B cells. Cepsilon and Cgamma(1) germline mRNA expression as well as NF-kappaB and STAT6 activation, events required for isotype switching, are also inhibited by CTLA-4 engagement. Together these findings show the critical role of CTLA-4 in the control of IL-4-driven isotype switching and suggest new approaches for modulating immediate-type hypersensitivity responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067906     DOI: 10.4049/jimmunol.165.10.5530

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  B lymphocytes and cancer: a love-hate relationship.

Authors:  Grace J Yuen; Ezana Demissie; Shiv Pillai
Journal:  Trends Cancer       Date:  2016-12

2.  Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF.

Authors:  Daniela Frasca; Richard L Riley; Bonnie B Blomberg
Journal:  Exp Gerontol       Date:  2006-10-25       Impact factor: 4.032

Review 3.  At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy.

Authors:  Andrew M Intlekofer; Craig B Thompson
Journal:  J Leukoc Biol       Date:  2013-04-26       Impact factor: 4.962

4.  Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes.

Authors:  Andrea Merlo; Claudya Tenca; Franco Fais; Lorenzo Battini; Ermanno Ciccone; Carlo E Grossi; Daniele Saverino
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

5.  Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosis.

Authors:  K Steiner; F Moosig; E Csernok; K Selleng; W L Gross; B Fleischer; B M Bröker
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

6.  CTLA-4 regulates allergen response by modulating GATA-3 protein level per cell.

Authors:  Francesca Nasta; Silvia Corinti; Angela Bonura; Paolo Colombo; Gabriella Di Felice; Claudio Pioli
Journal:  Immunology       Date:  2007-02-20       Impact factor: 7.397

Review 7.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

8.  CTLA-4 interacts with STAT5 and inhibits STAT5-mediated transcription.

Authors:  M Srahna; L A Van Grunsven; J E Remacle; P Vandenberghe
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

Review 9.  Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.

Authors:  A C Foks; J Kuiper
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

Review 10.  Immune Crosstalk Between Lymph Nodes and Breast Carcinomas, With a Focus on B Cells.

Authors:  Elena Alberts; Isobelle Wall; Dinis Pedro Calado; Anita Grigoriadis
Journal:  Front Mol Biosci       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.